|
Patients, n (%)
|
90 (100)
|
50 (55.6)
|
40 (44.4)
|
|
Age (years), mean (SD)
|
58.8 (15.8)
|
60.0 (16.0)
|
57.4 (15.6)
|
|
Gender
|
|
Male, n (%)
|
64 (71.1)
|
34 (68.0)
|
30 (75.0)
|
|
Female, n (%)
|
26 (28.9)
|
16 (32.0)
|
10 (25.0)
|
|
BMI, mean (SD)
|
30.7 (6.96)
|
29.1 (7.28)
|
32.9 (5.93)
|
|
Race
|
|
White, n (%)
|
43 (47.8)
|
24 (48.0)
|
19 (47.5)
|
|
Black, n (%)
|
16 (17.8)
|
9 (18.0)
|
7 (17.5)
|
|
Asian, n (%)
|
13 (14.4)
|
8 (16.0)
|
5 (12.5)
|
|
Other, n (%)
|
18 (20.0)
|
9 (18.0)
|
9 (22.5)
|
|
Transfers, n (%)
|
40 (44.4)
|
30 (60.0)
|
10 (25.0)
|
|
Dual MCS therapy (Impella, IABP)
|
34 (37.8)
|
25 (50.0)
|
9 (22.5)
|
|
Diabetes, n (%)
|
33 (36.7)
|
17 (34.0)
|
16 (40.0)
|
|
Hypertension, n (%)
|
59 (65.6)
|
31 (62.0)
|
28 (70.0)
|
|
Hyperlipidemia, n (%)
|
39 (43.3)
|
23 (46.0)
|
16 (40.0)
|
|
Congestive heart failure, n (%)
|
20 (22.2)
|
14 (28.0)
|
6 (15.0)
|
|
Peripheral vascular disease, n (%)
|
8 (8.9)
|
6 (12.0)
|
2 (5.0)
|
|
Coronary artery disease, n (%)
|
56 (62.2)
|
31 (62.0)
|
25 (62.5)
|
|
Chronic obstructive pulmonary disease, n (%)
|
7 (7.8)
|
4 (8.0)
|
3 (7.5)
|
|
CKD/ESRD, n (%)
|
12 (13.3)
|
9 (18.0)
|
3 (7.5)
|
|
Past myocardial infarction, n (%)
|
21 (23.3)
|
11 (22.0)
|
10 (25.0)
|
|
Past cerebrovascular accident, n (%)
|
10 (11.1)
|
8 (16.0)
|
2 (5.0)
|
|
Smoking, n (%)
|
22 (24.4)
|
11 (22.0)
|
11 (27.5)
|
|
Ventilator support, n (%)
|
69 (76.7)
|
35 (70.0)
|
34 (85.0)
|
|
AKI/ RF (prior to ECMO initiation), n (%)
|
12 (13.3)
|
10 (20.0)
|
2 (5.0)
|
